Actionable news
All posts from Actionable news
Actionable news in OPK: OPKO HEALTH Inc,

FDA Rejects Amgen Hormonal-Imbalance Treatment

Amgen Inc. AMGN -2.04 % said Wednesday that government regulators have rejected its new drug application for its therapy for a hormonal imbalance common in patients on dialysis.

Shares of the drugmaker slipped 0.35% to $170.25 in after-hours trading.

Amgen said it expects to meet with the U.S. Food and...